Free Trial

Venture Life Group (VLG) Competitors

Venture Life Group logo
GBX 50.70 -1.30 (-2.50%)
As of 10:48 AM Eastern

VLG vs. ANCR, DNL, EAH, STX, PXS, CHLL, MXC, RGT, CEL, and N4P

Should you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include Animalcare Group (ANCR), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and N4 Pharma (N4P). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Venture Life Group vs.

Animalcare Group (LON:ANCR) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Animalcare Group has higher revenue and earnings than Venture Life Group. Animalcare Group is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Animalcare Group£84.90M2.05£36.55M£53.644.74
Venture Life Group£51.77M1.25£747.21K£0.5986.04

In the previous week, Animalcare Group had 1 more articles in the media than Venture Life Group. MarketBeat recorded 1 mentions for Animalcare Group and 0 mentions for Venture Life Group. Venture Life Group's average media sentiment score of 0.37 beat Animalcare Group's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the news media.

Company Overall Sentiment
Animalcare Group Neutral
Venture Life Group Neutral

Animalcare Group has a net margin of 43.05% compared to Venture Life Group's net margin of 1.44%. Animalcare Group's return on equity of 36.62% beat Venture Life Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Animalcare Group43.05% 36.62% 2.97%
Venture Life Group 1.44%0.99%1.56%

Animalcare Group has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Venture Life Group has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500.

49.0% of Animalcare Group shares are held by institutional investors. Comparatively, 69.5% of Venture Life Group shares are held by institutional investors. 29.5% of Animalcare Group shares are held by insiders. Comparatively, 10.4% of Venture Life Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Venture Life Group received 2 more outperform votes than Animalcare Group when rated by MarketBeat users. Likewise, 72.90% of users gave Venture Life Group an outperform vote while only 69.37% of users gave Animalcare Group an outperform vote.

CompanyUnderperformOutperform
Animalcare GroupOutperform Votes
154
69.37%
Underperform Votes
68
30.63%
Venture Life GroupOutperform Votes
156
72.90%
Underperform Votes
58
27.10%

Summary

Animalcare Group beats Venture Life Group on 10 of the 15 factors compared between the two stocks.

Get Venture Life Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VLG vs. The Competition

MetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£64.61M£2.17B£5.35B£2.68B
Dividend Yield0.09%2.92%5.22%5.05%
P/E Ratio86.043.9826.84134.32
Price / Sales1.25529.96391.39203,702.45
Price / Cash6.4010.2538.2528.02
Price / Book0.866.926.793.79
Net Income£747,207.14£20.70B£3.23B£5.89B
7 Day Performance1.40%0.55%4.07%7.78%
1 Month Performance25.87%5.30%12.52%29.45%
1 Year Performance29.83%91.10%16.83%119.74%

Venture Life Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VLG
Venture Life Group
N/AGBX 50.70
-2.5%
N/A+30.1%£64.61M£51.77M86.04165News Coverage
ANCR
Animalcare Group
N/AGBX 248.80
+1.1%
N/A+7.6%£170.58M£84.90M4.64220High Trading Volume
DNL
Diurnal Group
N/AN/AN/AN/A£46.33M£4.68M-3.2133
EAH
ECO Animal Health Group
N/AGBX 62.90
+0.6%
N/A-47.9%£42.62M£89.44M40.66234Gap Up
High Trading Volume
STX
Shield Therapeutics
N/AGBX 2.35
-6.0%
N/A+36.0%£23.19M£20.92M-0.6140,000
PXS
Provexis
N/AGBX 0.52
-1.0%
N/A-11.0%£12.20M£846,984.38-19.714
CHLL
Chill Brands Group
N/AN/AN/AN/A£10.89M£624,187.00-215.007
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32M-13.255Gap Up
RGT
Argent BioPharma
N/AN/AN/AN/A£8.31MN/A-0.65N/AGap Down
High Trading Volume
CEL
Celadon Pharmaceuticals
N/AGBX 6
+20.0%
N/A-94.7%£3.68M£123,381.65-0.752,780Gap Up
N4P
N4 Pharma
N/AGBX 0.50
+5.3%
N/A-36.7%£2.15M£8,841.37-1.445Gap Down

Related Companies and Tools


This page (LON:VLG) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners